Literature DB >> 18804852

Immunosuppression of TH2 responses in Trichinella spiralis infection by Helicobacter pylori neutrophil-activating protein.

Gianfranco Del Prete1, Lorena Chiumiento, Amedeo Amedei, Maria Piazza, Mario M D'Elios, Gaia Codolo, Marina de Bernard, Massimo Masetti, Fabrizio Bruschi.   

Abstract

BACKGROUND: The Helicobacter pylori neutrophil-activating protein (HP-NAP) is able to induce IL-12 expression by cells of innate immunity and to shift to T(H)1 human allergen-specific T(H)2 cells in vitro.
OBJECTIVE: We performed an in vivo investigation of the ability of HP-NAP to downmodulate the T(H)2 response induced in mice by Trichinella spiralis infection.
METHODS: Groups of T spiralis-infected BALB/c mice received intraperitoneal PBS/rat IgG2b (control animals) or 10 microg of HP-NAP with or without anti-Toll-like receptor 2 antibody on days 10 and 28 after infection. Blood eosinophils, total and T spiralis-specific IgE levels, and cytokine levels were measured in the plasma up to day 42, when splenocytes were cultured for cytokine production.
RESULTS: Although control animals showed significant eosinophilia and increase of total and T spiralis-specific IgE, IL-4, and IL-5 levels from days 10 to 14, HP-NAP-treated animals showed less eosinophilia and total and excretory/secretory antigens of T spiralis-specific IgE in the blood. HP-NAP-treated animals also had higher IL-12 and IFN-gamma plasma levels and lower IL-4 and IL-5 levels. The addition of anti-Toll-like receptor 2 antibody abrogated the anti-T(H)2/pro-T(H)1 activity of HP-NAP.
CONCLUSION: This study provides evidence that HP-NAP enhances endogenous IL-12 and IFN-gamma response and exerts a powerful anti-T(H)2 activity in vivo, targeting both IL-5-induced eosinophilia and IL-4-mediated hyper-IgE responses induced by parasitic infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804852     DOI: 10.1016/j.jaci.2008.08.016

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  25 in total

1.  Infection of non-encapsulated species of Trichinella ameliorates experimental autoimmune encephalomyelitis involving suppression of Th17 and Th1 response.

Authors:  Zhiliang Wu; Isao Nagano; Kazunobu Asano; Yuzo Takahashi
Journal:  Parasitol Res       Date:  2010-07-27       Impact factor: 2.289

2.  Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein.

Authors:  Ianko D Iankov; Iana H Haralambieva; Evanthia Galanis
Journal:  Vaccine       Date:  2010-12-21       Impact factor: 3.641

3.  One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode.

Authors:  Ting-Yu Kuo; Zhi-Wei Hong; Chung-Che Tsai; Yu-Chi Yang; Hua-Wen Fu
Journal:  J Vis Exp       Date:  2016-06-18       Impact factor: 1.355

4.  Helicobacter pylori neutrophil-activating protein induces release of histamine and interleukin-6 through G protein-mediated MAPKs and PI3K/Akt pathways in HMC-1 cells.

Authors:  Chung-Che Tsai; Ting-Yu Kuo; Zhi-Wei Hong; Ying-Chieh Yeh; Kuo-Shun Shih; Shin-Yi Du; Hua-Wen Fu
Journal:  Virulence       Date:  2015-09-16       Impact factor: 5.882

Review 5.  Immune evasion strategies used by Helicobacter pylori.

Authors:  Taslima T Lina; Shatha Alzahrani; Jazmin Gonzalez; Irina V Pinchuk; Ellen J Beswick; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

6.  A Campylobacter jejuni Dps homolog has a role in intracellular survival and in the development of campylobacterosis in neonate piglets.

Authors:  James R Theoret; Kerry K Cooper; Robert D Glock; Lynn A Joens
Journal:  Foodborne Pathog Dis       Date:  2011-08-21       Impact factor: 3.171

7.  Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus.

Authors:  Ianko D Iankov; Cory Allen; Mark J Federspiel; Rae M Myers; Kah Whye Peng; James N Ingle; Stephen J Russell; Evanthia Galanis
Journal:  Mol Ther       Date:  2012-02-14       Impact factor: 11.454

8.  Potential protective effect of Helicobacter pylori on the development of gastrointestinal GvHD.

Authors:  A Velasco-Guardado; A Mora-Soler; L López-Corral; O López-Godino; L Vázquez-López; O Blanco-Muñez; E Pérez-López; A Rodríguez-Pérez; D Caballero-Barrigón
Journal:  Bone Marrow Transplant       Date:  2016-03-07       Impact factor: 5.483

Review 9.  Advances in basic and clinical immunology in 2008.

Authors:  Javier Chinen; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2009-02       Impact factor: 10.793

Review 10.  Immunity against helminths: interactions with the host and the intercurrent infections.

Authors:  Emmanuelle Moreau; Alain Chauvin
Journal:  J Biomed Biotechnol       Date:  2010-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.